Nonadministration of pharmacologic venous thromboembolism prophylaxis is less common in hospitalized patients with COVID-19.

Mujan Varasteh KiaBrandyn D LauOluwafemi P OwodunniPeggy S KrausChristine G HolzmuellerDeborah B HobsonDauryne L ShafferMichael B StreiffElliott R Haut

Published in: Journal of thrombosis and thrombolysis (2021)

It is unlikely that high rates of VTE in COVID-19 are due to nonadministration of doses of pharmacologic prophylaxis. Hence, we should prioritize research into alternative approaches to optimizing VTE prevention in patients with COVID-19.

Keyphrases

venous thromboembolism
direct oral anticoagulants
coronavirus disease
sars cov
respiratory syndrome coronavirus